Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 553

1.

TRPC6 inactivation does not affect loss of renal function in nephrotoxic serum glomerulonephritis in rats, but reduces severity of glomerular lesions.

Kim EY, Shotorbani PY, Dryer SE.

Biochem Biophys Rep. 2019 Jan 8;17:139-150. doi: 10.1016/j.bbrep.2018.12.006. eCollection 2019 Mar.

PMID:
30662960
2.

MeSsAGe risk score: tool for renal biopsy decision in steroid-dependent nephrotic syndrome.

Chan CY, Resontoc LP, Qader MA, Chan YH, Liu ID, Lau PY, Than M, Yeo WS, Loh AH, Tan PH, Wei C, Reiser J, Biswas SK, Ng KH, Yap HK.

Pediatr Res. 2019 Jan 15. doi: 10.1038/s41390-019-0277-z. [Epub ahead of print]

PMID:
30659270
3.

suPAR in the assessment of post intensive care unit prognosis: a pilot study.

Silvestre J, Coelho L, Pereira JG, Mendes V, Tapadinhas C, Póvoa P.

Rev Bras Ter Intensiva. 2019 Jan 10. pii: S0103-507X2019005001101. doi: 10.5935/0103-507X.20180062. [Epub ahead of print] Portuguese, English.

4.

Blood markers of cardiac stress after generalized convulsive seizures.

Nass RD, Motloch LJ, Paar V, Lichtenauer M, Baumann J, Zur B, Hoppe UC, Holdenrieder S, Elger CE, Surges R.

Epilepsia. 2019 Jan 15. doi: 10.1111/epi.14637. [Epub ahead of print]

PMID:
30645779
5.

Salivary levels of MPO, MMP-8 and TIMP-1 are associated with gingival inflammation response patterns during experimental gingivitis.

Nascimento GG, Baelum V, Sorsa T, Tervahartiala T, Skottrup PD, López R.

Cytokine. 2019 Jan 6. pii: S1043-4666(18)30477-0. doi: 10.1016/j.cyto.2018.12.002. [Epub ahead of print]

PMID:
30626536
6.

Increased soluble urokinase plasminogen activator receptor (suPAR) levels in neovascular age-related macular degeneration: a role for inflammation in the pathogenesis of the disease?

Scotti F, Milani P, Setaccioli M, Maestroni S, Sidenius N, De Lorenzi V, Massacesi A, Bergamini F, Zerbini G.

Graefes Arch Clin Exp Ophthalmol. 2019 Jan 7. doi: 10.1007/s00417-018-04230-w. [Epub ahead of print]

PMID:
30617582
7.

Serum heart-type fatty acid-binding protein decreases and soluble isoform of suppression of tumorigenicity 2 increases significantly by long-term physical activity.

Sponder M, Lichtenauer M, Wernly B, Paar V, Hoppe U, Emich M, Fritzer-Szekeres M, Litschauer B, Strametz-Juranek J.

J Investig Med. 2018 Dec 27. pii: jim-2018-000913. doi: 10.1136/jim-2018-000913. [Epub ahead of print]

PMID:
30593542
8.

Monitoring suPAR levels in post-kidney transplant focal segmental glomerulosclerosis treated with therapeutic plasma exchange and rituximab.

Alachkar N, Li J, Matar D, Vujjini V, Alasfar S, Tracy M, Reiser J, Wei C.

BMC Nephrol. 2018 Dec 17;19(1):361. doi: 10.1186/s12882-018-1177-x.

9.

The role of soluble urokinase plasminogen activator receptor (SuPAR) as an indicator of the severity of acute pancreatitis

Küçükceran K, Ergin M, Kılınç İ, Karaibrahimoğlu A, Çolak T, Tuncar A, Dündar ZD, Koçak S, Girişgin AS, Gül M, Cander B.

Turk J Med Sci. 2018 Dec 12;48(6):1175-1181. doi: 10.3906/sag-1709-134.

PMID:
30541244
10.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) is predictive of Non-AIDS Events during Antiretroviral Therapy-mediated Viral Suppression.

Hoenigl M, Moser C, Funderburg N, Bosch R, Kantor A, Zhang Y, Eugen-Olsen J, Finkelman M, Reiser J, Landay A, Moisi D, Lederman MM, Gianella S; ACTG NWCS 411 study team.

Clin Infect Dis. 2018 Nov 12. doi: 10.1093/cid/ciy966. [Epub ahead of print]

PMID:
30418519
11.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) as an Added Predictor to Existing Preoperative Risk Assessments.

Alstrup M, Meyer J, Schultz M, Rasmussen LJH, Rasmussen LS, Køber L, Forberg JL, Eugen-Olsen J, Iversen K.

World J Surg. 2018 Nov 2. doi: 10.1007/s00268-018-4841-1. [Epub ahead of print]

PMID:
30390135
12.

Kidney function estimates using cystatin C versus creatinine: Impact on medication prescribing in acutely hospitalized elderly patients.

Iversen E, Bodilsen AC, Klausen HH, Treldal C, Andersen O, Houlind MB, Petersen J.

Basic Clin Pharmacol Toxicol. 2018 Oct 29. doi: 10.1111/bcpt.13156. [Epub ahead of print]

PMID:
30372593
13.

Mechanisms underlying modulation of podocyte TRPC6 channels by suPAR: Role of NADPH oxidases and Src family tyrosine kinases.

Kim EY, Hassanzadeh Khayyat N, Dryer SE.

Biochim Biophys Acta Mol Basis Dis. 2018 Oct;1864(10):3527-3536. doi: 10.1016/j.bbadis.2018.08.007. Epub 2018 Aug 8.

PMID:
30293571
14.

Fetal Renal Echogenicity Associated with Maternal Focal Segmental Glomerulosclerosis: The Effect of Transplacental Transmission of Permeability Factor suPAR.

Shuster S, Ankawi G, Licht C, Reiser J, Wang X, Wei C, Chitayat D, Hladunewich M.

J Clin Med. 2018 Oct 4;7(10). pii: E324. doi: 10.3390/jcm7100324.

15.

Combining National Early Warning Score With Soluble Urokinase Plasminogen Activator Receptor (suPAR) Improves Risk Prediction in Acute Medical Patients: A Registry-Based Cohort Study.

Rasmussen LJH, Ladelund S, Haupt TH, Ellekilde GE, Eugen-Olsen J, Andersen O.

Crit Care Med. 2018 Dec;46(12):1961-1968. doi: 10.1097/CCM.0000000000003441.

16.

Plasma Soluble Urokinase Plasminogen Activator Receptor Levels in Systemic Lupus Erythematosus Patients.

Zaitoon YA, Shehab AA, Mohamed NA, Morad CS, Yassine EM.

Egypt J Immunol. 2018 Jan;25(1):35-43.

PMID:
30242996
17.

Concentration of soluble urokinase plasminogen activator receptor (suPAR) in the pre-ovulatory follicular fluid is associated with development of ovarian hyperstimulation syndrome during ovarian stimulation.

Grynnerup AG, Toftager M, Zedeler A, Bogstad JW, Prætorius L, Grøndahl ML, Yding Andersen C, Sørensen S, Pinborg A, Løssl K.

J Assist Reprod Genet. 2018 Dec;35(12):2187-2193. doi: 10.1007/s10815-018-1314-2. Epub 2018 Sep 19.

PMID:
30232642
18.

Mechanisms underlying the J-curve for diastolic blood pressure: Subclinical myocardial injury and immune activation.

Topel ML, Sandesara PB, Stahl EP, Hayek SS, Tahhan AS, O'Neal WT, Ko YA, Alkhoder A, Gafeer MM, Kim JH, Wilson PWF, Shaw LJ, Epstein SE, Vaccarino V, Sperling LS, Quyyumi AA.

Int J Cardiol. 2019 Feb 1;276:255-260. doi: 10.1016/j.ijcard.2018.09.028. Epub 2018 Sep 8.

PMID:
30217423
19.

Soluble Urokinase Plasminogen Activator Receptor (suPAR) and All-Cause and Cardiovascular Mortality in Diverse Hemodialysis Patients.

Torino C, Pizzini P, Cutrupi S, Postorino M, Tripepi G, Mallamaci F, Reiser J, Zoccali C; PROGREDIRE Working Group.

Kidney Int Rep. 2018 May 22;3(5):1100-1109. doi: 10.1016/j.ekir.2018.05.004. eCollection 2018 Sep.

20.

SuPAR, an emerging biomarker in kidney and inflammatory diseases.

Hamie L, Daoud G, Nemer G, Nammour T, El Chediak A, Uthman IW, Kibbi AG, Eid A, Kurban M.

Postgrad Med J. 2018 Sep;94(1115):517-524. doi: 10.1136/postgradmedj-2018-135839. Epub 2018 Sep 3. Review.

PMID:
30177549

Supplemental Content

Loading ...
Support Center